Paraphenylenediamine (PPD) is a frequent and potent sensitizer producing many cases of allergic eczematous contact-type dermatitis.
A review of the patient material of our Allergy Section from 1949 through 1956 reveals that PPD is one of the most common causes of patch test reactions. Of 712 patients referred to the Allergy Section for patch testing during 1956 who were tested to PPD, 26 (3.6%) gave strongly positive (3 or 4+) reactions.
PPD (H2N-C6H4-NH2) is used principally in hair and fur dying. It may cross react, allergenically or immunologically, with other chemicals having an amino grouping in the para position on the benzene ring. These include certain dyes, local anesthetics, para-aminobenzoie acid and the sulfonamides. This paper deals with the persistence of PPD sensitivity, some aspects of the cross sensitivity pattern of this substance, and the clinical significance of these findings.
METHODS AND REsULTS
In 1956, 50 patients with positive patch test reactions to PPD during the period from 1946 to 1953 returned to the Allergy Section for further investigation. The group consisted of 38 women and 12 men, ranging in age from 18 to 70. 18 had had 4+ reactions, 26 had had 3+ reactions, 6 had had 2+ reactions. In 1956 these patients were patch tested with 2% PPD in petrolatum, 5% benzocaine in petrolatum, 1% aqueous procaine hydrochloride, 5% para-aminobenzoic acid( PABA) in petrolatum, and 5% sulfanilimide in petrolatum. PPD sensitivity with that of other allergens similarly studied. Once established, allergic hypersensitivity to many simple chemicals is maintained for long periods of time (1-3). However "spontaneous" loss of sensitivity to some allergens has been observed (4). The persistence of allergic eezematous contact-type sensitization varies from substance to substance. PPD appears to belong with benzocaine, nickel, *5% Carbutamide (1 butyl-3-p-aminobenzesulfonurea) in petrolatum and 5% tolbutamide.
(1 -butyl-3-p-tolysulfonurea) in petrolatum. These tests were suggested by Dr. R. L. Baer, who supplied the materials for patch testing. and ragweed oleoreSin to that group of chemicals in which allergic hypersensitivity may be repeatedly demonstrated years after the initial sensitization has taken place. Hypersensitivity to dichromate, on the other hand, is much less consistently maintained over a period of years. Any evaluation of desensitization procedures must be based on a knowledge of the natural persistence, or lack of persistence, of the hypersensitivity to the substance in question. Baer (5) suggested that repeated exposure to a specific allergen might increase the level of sensitivity to that substance. Several of the PPD positive women in this study repeatedly exposed themselves to PPD (in hair dyes) without any increase in their PPD sensitivity as measured by patch tests. Repeated patch testing with PPD also appeared to have no effect on the level of sensitivity to the test substance. 11 of our 46 PPD positive patients were also sensitive to benzocaine. Many of these patients had been exposed to both allergens so it was not possible to determine which substance was the primary allergen. These findings agree generally with those of Tzanck, Sidi, and Dobkevitch-Morrill (6) who reported that a minority of their patients with a 'primary' sensitization to PPD developed cross-reactions to local anesthetics. On the other hand, these investigators reported that a majority of their patients with 'primary' sensitization to local anesthetics manifested cross-sensitization to PPD. We found in a separate study of 24 benzocaine positive patients in whom it appeared probable that benzocaine was the 'primary' allergen, that 10 showed hypersensitivity to PPD as well.
All three of our patients who reacted to both PPD and procaine also reacted to benzocaine. Baer (7) reported that three of seven PPD positive patients reacted to both procaine and benzocaine. Sidi and Dobkevitch-Morrill (8) also reported seven patients who reacted to PPD and procaine and ointments containing local anesthetics (not benzocaine). The possibility that 'primary' sensitization to PPD or benzocaine may pave the way for severe reactions to procaine administered at a later date will be dealt with more fully in another publication.
It has been suggested that repeated exposure to a specific allergen might widen the spectrum of sensitization (7). The patient-material reviewed in this paper includes 5 PPD positive women who repeatedly exposed themselves to this material over a period of several years. These exposures always caused a severe dermatitis. These patients showed no widening of their spectmm of sensitivity. They maintained hypersensitivity to PPD and did not react to the other related compounds with which we tested them.
Nor did repeated patch testing of these PPD positive patients with other compounds containing the para-amino benzyl grouping sensitize to the other compounds.
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Our study indicates that PPD sensitivity, once established, persists for years. The spectrum of cross sensitivity to PPD appears to be related to an individual "host" factor and to be established early. The spectrum of cross sensitivity does not as a rule widen later even with repeated exposure to the allergens in question. Only one of our patients showed a "spread", or widening, of his PPD sensitivity to henzocaine and procaine over a three year period. A broad pattern of cross sensitivity seems to be the exception rather than the rule. There was no difference in the findings between the younger and the older age groups in our material.
Baer (7) has pointed out the unpredictability of an individual's pattern of sensitization. No two of his 9 PPD positive patients showed identical patterns when tested to 20 related allergens. Strauss (9) concluded that only patch testing or clinical exposure can determine whether a hypersensitive individual will react to one or more or all of a group of related compounds. Furthermore in cases of multiple reactions of cross sensitivity, it may be very difficult or impossible to determine the 'primary' allergen if there has been exposure to several of the related substances. An interesting factor in this series is that none of these patients had previously used hair dye, which indicates some sort of cross-sensitization to certain substances we have not elicited. It also has been our interest to investigate crosssensitizing phenomenon. For that purpose we used procaine. Amongst the 8 positive reactors only 2 showed positive reaction to procaine. On retesting 301 patients at intervals of from three to four weeks, once on 301 persons and twice on 67 persons, no change developed in the speci-ficity of the reaction. In only one patient who was found sensitive to the dye, early repetition gave weaker reactions and the repetition on three occasions a year later gave negative results. DR. R. L. MAYER (Summit, N. J.): Sensitization patterns of various compounds belonging to the same antigenic group are most variable; this is one of the most curious aspects of the sensitization problem. It is a priori quite difficult to understand why patients primarily sensitized to p-phenylenediamine are more often sensitive to procaine than vice versa. The reasons for the existence of various patterns within a specific type of cross-sensitization is probably due to the fact that the sensitization is not caused by the original substance, but by metabolites. It is established that different metabolites are formed within the same group; they all constitute direct sensitizers of different potency. In the case of p-phenylenediamine, for instance, and of compounds related to it, the antigenic active metabolites are all compounds of quinone structure, and I have for this reason called this sensitiza- Reiss mentioned the incidence of PPD sensitivity. In our series there were 1712 patients who were tested to PPD. 3.6 per cent reacted to this substance. We interviewed some of the beauty parlors in New York City to see how many patients they rejected because of a positive patch test. The "better" beauty parlors 
